MetaCap

Who Owns UroGen Pharma Stock?

NASDAQ: URGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

27.65-4.08 (-12.86%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
96.49%
Institutional holders
297
  • Institutions 96.5%
  • Insiders 3.5%
  • Public and other 0.0%

Who owns UroGen Pharma stock?

Institutional investors own about 96.5% of UroGen Pharma's shares, spread across 297 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 3.48% of URGN.

The largest institutional holders are RTW Investments LP (9.26%), Blackrock Inc. (6.34%) and Kynam Capital Management, LP (4.96%). Together, the top 10 institutions control 45.4% of shares outstanding. In their latest filings, 2 of the top 10 institutions increased their URGN positions and 4 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of URGN

UroGen Pharma top institutional holders
InstitutionShares% HeldChange
RTW Investments LP4.54M9.26%0.0%
Blackrock Inc.3.11M6.34%-2.9%
Kynam Capital Management, LP2.43M4.96%0.0%
Jefferies Financial Group Inc.2.20M4.48%0.0%
Morgan Stanley2.17M4.43%-15.6%
SG Americas Securities, LLC2.05M4.19%+23.8%
Acorn Capital Advisors, LLC 1.65M3.36%-1.5%
Opaleye Management Inc.1.44M2.94%0.0%
American Century Companies Inc1.38M2.80%-18.4%
Shaw D.E. & Co., Inc.1.28M2.62%+12.1%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of URGN

UroGen Pharma top fund holders
FundShares% Held
iShares Trust-iShares Russell 2000 ETF1.10M2.25%
American Century Mutual Funds, Inc.-Small Cap Growth Fund874.98K1.78%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund466.10K0.95%
iShares Trust-iShares Russell 2000 Growth ETF343.76K0.70%
iShares Trust-iShares Biotechnology ETF323.80K0.66%
VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund244.15K0.50%
Fidelity Commonwealth Trust II-Fidelity Enhanced Small Cap Core ETF209.22K0.43%
SPDR INDEX SHARES Fd.S-State Street SPDR PORT. Developed World ex-US E187.69K0.38%
iShares Trust-iShares Micro-Cap ETF134.39K0.27%
VANGUARD SCOTTSDALE FUNDS-Vanguard Explorer Value Fund127.64K0.26%

Frequently asked questions

Who is the largest shareholder of UroGen Pharma?

RTW Investments LP is the largest institutional shareholder of URGN, owning 9.26% of shares outstanding (4.54M shares) as of its latest 13F filing.

What percentage of UroGen Pharma is owned by institutions?

Institutions own about 96.5% of URGN shares and 100.0% of the public float.

How much of UroGen Pharma do insiders own?

Insiders, such as officers and directors, own about 3.48% of URGN shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related